Selective Translation of Cell Fate Regulators Mediates Tolerance to Broad Oncogenic Stress

Elise Y Cai1, Megan N Kufeld2, Samantha Schuster3

  • 1Division of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA; Medical Scientist Training Program, University of Washington, Seattle, WA 98195, USA; Molecular and Cellular Biology Graduate Program, University of Washington, Seattle, WA 98195, USA.

Cell Stem Cell
|June 10, 2020
PubMed

Insights

Human skin can tolerate many oncogenic lesions. A new study reveals a translational mechanism involving eIF2B5 that coordinates HRAS-driven proliferation with progenitor cell loss, preventing tumor growth.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Dermatology

Background:

  • Human skin exhibits remarkable tolerance to oncogenic lesions.
  • Mechanisms controlling tolerance to widespread oncogene activation in tissues remain largely unknown.

Purpose of the Study:

  • To investigate the translational mechanisms coordinating oncogene-induced proliferation and progenitor cell fate in skin.
  • To identify key regulators of oncogene tolerance and tumorigenesis.

Main Methods:

  • In vivo ribosome profiling to analyze translation dynamics.
  • Genetic screening to identify regulatory genes.
  • Analysis of HRAS oncogene activation in epidermal tissue.

Main Results:

  • Oncogenic HRAS triggers hyperproliferation coupled with loss of progenitor self-renewal via a translational mechanism.
  • Translation initiator eIF2B5 is identified as a key regulator of HRAS-driven proliferation and cell fate.
  • FBXO32, a ubiquitin ligase, restrains epidermal renewal, thereby limiting HRAS-driven tumorigenesis while preserving normal tissue growth.

Conclusions:

  • Translational control plays a critical role in managing oncogenic stress in tissues.
  • eIF2B5-mediated translation of ubiquitination genes directs progenitor cell fate to prevent widespread tumorigenesis.
  • Oncogene-driven translation can be a protective mechanism, steering cell fate to maintain normal tissue function under stress.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
10.9K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.7K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.3K
Regulation of Expression at Multiple Steps01:23

Regulation of Expression at Multiple Steps

The gene expression in cells is regulated at different stages: (i) transcription, (ii) RNA processing, (iii) RNA localization, and (iv) translation. Transcriptional regulation is mediated by regulatory proteins such as transcription factors, activators, or repressors—these control gene expression by initiating or inhibiting the transcription of genes. Once a precursor or pre-mRNA is produced, it undergoes post-transcriptional modification, including 5' capping, splicing, and the...
1.3K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.1K